| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oruka Therapeutics, Inc. (ORKA) has 5 insiders with recent SEC Form 4 filings, including 5 buys and 26 sells. ORKA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 236.4K | $22.97M | - | |
| 10% | 94.5K | $9.18M | - | |
| Other | 39.3K | $3.82M | -7,000 | |
| Dir | 35.0K | $3.40M | - | |
| VP | 23.9K | $2.32M | -9,999 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Goncalves Joana89 | Chief Medical Officer | Sale+OE | 7,000 | $86.28 | $603,937.77 | -4.7% | - | - | |
| Jul 13, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sale+OE | 9,999 | $84.63 | $846,180.21 | -11.5% | - | - | |
| Jul 1, 2026 | Fairmount Funds Management LLC74 | Director, 10% Owner | Sell | 3,553,410 | $84.43 | $300,014,406.30 | -75.8% | - | - | |
| Jul 1, 2026 | Sandler Laura Lee | Chief Operating Officer | Sale+OE | 5,000 | $94.42 | $472,078.58 | -0.7% | - | - | |
| Jun 22, 2026 | Agarwal Arjun | Senior Vice President, Finance | Sell | 1,587 | $80.95 | $128,468.24 | -4.8% | - | - | |
| Apr 15, 2026 | Goncalves Joana89 | Chief Medical Officer | Sale+OE | 7,000 | $66.12 | $462,829.56 | -6.3% | +33.4% | - | |
| Jan 15, 2026 | Goncalves Joana89 | Chief Medical Officer | Sale+OE | 7,000 | $31.81 | $222,704.45 | -55.3% | +83.3% | - | |
| Jan 2, 2026 | Sandler Laura Lee | Chief Operating Officer | Sale+OE | 13,000 | $28.52 | $370,795.08 | -2.1% | +78.4% | - | |
| Dec 19, 2025 | Goncalves Joana89 | Chief Medical Officer | Sale+OE | 7,000 | $30.61 | $214,293.02 | -25.8% | +21.9% | - | |
| Feb 14, 2025 | Venrock Healthcare Capital Partners Iii, L.P.54 | 10% Owner | Buy | 122,882 | $11.45 | $1,407,367.87 | +0.6% | -15.4% | +188.1% |